Unbound MEDLINE

Rapid determination of total benzalkonium chloride content in ophthalmic formulation.

Abstract

A simple and rapid reversed-phase HPLC method was developed for routine analysis of total benzalkonium chloride in ophthalmic formulations. The analysis involves simple sample preparation using the mobile phase as the diluent. The method uses a Waters SymmetryShield RP-18 (75 mm x 4.6 mm, 3.5 microm particle size) column and a mobile phase consisting of a mixture of methanol-potassium phosphate (pH 3.0; 7.5 mM) (68:32, v/v). Using these conditions, three major homologs of the benzalkonium chloride (C(12), C(14) and C(16)) were separated in less then 7 min. Furthermore, recoveries ranging from 97% to 99% at three levels of the label claim of total benzalkonium chloride content were obtained for different ophthalmic formulations. Data supporting the development and validation of this method are presented.

Links

  • Publisher Full Text
  • Authors

    Labranche LP, Dumont SN, Levesque S, Carrier A

    Institution

    Sandoz Canada Inc., 145 Jules-Léger Boucherville, Québec J4B 7K8, Canada.

    Source

    Journal of pharmaceutical and biomedical analysis 43:3 2007 Feb 19 pg 989-93

    MeSH

    Anti-Infective Agents, Local
    Benzalkonium Compounds
    Chemistry, Pharmaceutical
    Chromatography, High Pressure Liquid
    Indicators and Reagents
    Ophthalmic Solutions
    Reference Standards
    Solutions
    Spectrophotometry, Ultraviolet

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    17045769